[1]
|
Adams DH, Popma JJ, Reardon MJ, et al. (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370: 1790-1798. doi: 10.1056/NEJMoa1400590
|
[2]
|
Leon MB, Smith CR, Mack M, et al. (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363: 1597-1607. doi: 10.1056/NEJMoa1008232
|
[3]
|
Popma JJ, Adams DH, Reardon MJ, et al. (2014) Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63: 1972-1981. doi: 10.1016/j.jacc.2014.02.556
|
[4]
|
Smith CR, Leon MB, Mack MJ, et al. (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364: 2187-2198. doi: 10.1056/NEJMoa1103510
|
[5]
|
O'Brien SM, Shahian DM, Filardo G, et al. (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 88: S23-42. doi: 10.1016/j.athoracsur.2009.05.056
|
[6]
|
Messe SR, Acker MA, Kasner SE, et al. (2014) Stroke after aortic valve surgery: results from a prospective cohort. Circulation 129: 2253-2261. doi: 10.1161/CIRCULATIONAHA.113.005084
|
[7]
|
Leon MB, Piazza N, Nikolsky E, et al. (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 32: 205-217. doi: 10.1093/eurheartj/ehq406
|
[8]
|
Kappetein AP, Head SJ, Genereux P, et al. (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J 33: 2403-2418. doi: 10.1093/eurheartj/ehs255
|
[9]
|
Spaziano M, Francese DP, Leon MB, et al. (2014) Imaging and functional testing to assess clinical and subclinical neurological events after transcatheter or surgical aortic valve replacement: a comprehensive review. J Am Coll Cardiol 64: 1950-1963. doi: 10.1016/j.jacc.2014.07.986
|
[10]
|
Eifert S, Reichenspurner H, Pfefferkorn T, et al. (2003) Neurological and neuropsychological examination and outcome after use of an intra-aortic filter device during cardiac surgery. Perfusion 18 Suppl 1: 55-60.
|
[11]
|
Alassar A, Roy D, Valencia O, et al. (2013) Cerebral embolization during transcatheter aortic valve implantation compared with surgical aortic valve replacement (abstr.). Interact Cardiovasc Thorac Surg 17: S134-S135.
|
[12]
|
Jones BM, Tuzcu EM, Krishnaswamy A, et al. (2015) Neurologic events after transcatheter aortic valve replacement. Interventional Cardiology Clinics 4: 83-93. doi: 10.1016/j.iccl.2014.09.005
|
[13]
|
Hauville C, Ben-Dor I, Lindsay J, et al. (2012) Clinical and silent stroke following aortic valve surgery and transcatheter aortic valve implantation. Cardiovasc Revasc Med 13: 133-140. doi: 10.1016/j.carrev.2011.11.001
|
[14]
|
Bucerius J, Gummert JF, Borger MA, et al. (2003) Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 75: 472-478. doi: 10.1016/S0003-4975(02)04370-9
|
[15]
|
Thourani VH, Ailawadi G, Szeto WY, et al. (2011) Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg 91: 49-55; discussion 55-46. doi: 10.1016/j.athoracsur.2010.09.040
|
[16]
|
Eggebrecht H, Schmermund A, Voigtlander T, et al. (2012) Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention8: 129-138.
|
[17]
|
Miller DC, Blackstone EH, Mack MJ, et al. (2012) Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 143: 832-843 e813. doi: 10.1016/j.jtcvs.2012.01.055
|
[18]
|
Tay EL, Gurvitch R, Wijesinghe N, et al. (2011) A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv 4: 1290-1297. doi: 10.1016/j.jcin.2011.08.012
|
[19]
|
Stortecky S, Windecker S, Pilgrim T, et al. (2012) Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes. EuroIntervention 8: 62-70. doi: 10.4244/EIJV8I1A11
|
[20]
|
Nuis RJ, Van Mieghem NM, Schultz CJ, et al. (2012) Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am J Cardiol 109: 1637-1643. doi: 10.1016/j.amjcard.2012.01.389
|
[21]
|
Mack MJ, Brennan JM, Brindis R, et al. (2013) Outcomes following transcatheter aortic valve replacement in the United States. JAMA 310: 2069-2077. doi: 10.1001/jama.2013.282043
|
[22]
|
Hamon M, Baron JC, Viader F (2008) Periprocedural stroke and cardiac catheterization. Circulation 118: 678-683. doi: 10.1161/CIRCULATIONAHA.108.784504
|
[23]
|
Omran H, Schmidt H, Hackenbroch M, et al. (2003) Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361: 1241-1246. doi: 10.1016/S0140-6736(03)12978-9
|
[24]
|
Letac B, Cribier A, Koning R, et al. (1988) Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis. Am J Cardiol 62: 598-605. doi: 10.1016/0002-9149(88)90663-7
|
[25]
|
Hahn RT, Pibarot P, Webb J, et al. (2014) Outcomes With Post-Dilation Following Transcatheter Aortic Valve Replacement: The PARTNER I Trial (Placement of Aortic Transcatheter Valve). JACC Cardiovasc Interv 7: 781-789. doi: 10.1016/j.jcin.2014.02.013
|
[26]
|
Amat-Santos IJ, Rodes-Cabau J, Urena M, et al. (2012) Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation. J Am Coll Cardiol 59: 178-188. doi: 10.1016/j.jacc.2011.09.061
|
[27]
|
Shults C, Gunter R, Thourani VH (2012) The versatility of transapical access: Will it lead to a completely new approach to valvular therapy? Ann Cardiothorac Surg 1: 220-223.
|
[28]
|
Athappan G, Gajulapalli RD, Sengodan P, et al. (2014) Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature. J Am Coll Cardiol 63: 2101-2110. doi: 10.1016/j.jacc.2014.02.540
|
[29]
|
Abdel-Wahab M, Mehilli J, Frerker C, et al. (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311: 1503-1514. doi: 10.1001/jama.2014.3316
|
[30]
|
Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, et al. (2012) Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv 5: 499-512.
|
[31]
|
Whitlock RP, Sun JC, Fremes SE, et al. (2012) Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: e576S-600S.
|
[32]
|
Holmes DR, Jr., Mack MJ, Kaul S, et al. (2012) 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 59: 1200-1254. doi: 10.1016/j.jacc.2012.01.001
|
[33]
|
Ussia GP, Scarabelli M, Mule M, et al. (2011) Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 108: 1772-1776. doi: 10.1016/j.amjcard.2011.07.049
|
[34]
|
Sergie Z, Lefevre T, Van Belle E, et al. (2013) Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies. J Thromb Thrombolysis 35: 483-493. doi: 10.1007/s11239-013-0890-3
|
[35]
|
Freeman M, Barbanti M, Wood DA, et al. (2014) Cerebral events and protection during transcatheter aortic valve replacement. Catheter Cardiovasc Interv.
|
[36]
|
Nietlispach F, Wijesinghe N, Gurvitch R, et al. (2010) An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 3: 1133-1138. doi: 10.1016/j.jcin.2010.05.022
|
[37]
|
Onsea K, Agostoni P, Samim M, et al. (2012) First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 8: 51-56. doi: 10.4244/EIJV8I1A9
|
[38]
|
Naber CK, Ghanem A, Abizaid AA, et al. (2012) First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8: 43-50. doi: 10.4244/EIJV8I1A8
|
[39]
|
Banbury MK, Kouchoukos NT, Allen KB, et al. (2003) Emboli capture using the Embol-X intraaortic filter in cardiac surgery: a multicentered randomized trial of 1,289 patients. Ann Thorac Surg 76: 508-515; discussion 515. doi: 10.1016/S0003-4975(03)00530-7
|
[40]
|
Ye J, Webb JG (2014) Embolic capture with updated intra-aortic filter during coronary artery bypass grafting and transaortic transcatheter aortic valve implantation: First-in-human experience. J Thorac Cardiovasc Surg.
|
[41]
|
Etienne PY, Papadatos S, Pieters D, et al. (2011) Embol-X intraaortic filter and transaortic approach for improved cerebral protection in transcatheter aortic valve implantation. Ann Thorac Surg 92: e95-96. doi: 10.1016/j.athoracsur.2011.05.109
|